Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 341

Three leading Aussie stocks dependent on China

The signing of the phase one agreement by US President Donald Trump and Chinese Vice Premier Liu marks a thaw in the 18-month row between the world's two largest economies.

But scepticism remains because the deal doesn't fully eliminate the tariffs that have slowed the global economy. It also sets hard-to-achieve purchase targets.

Companies dependent on China

Looking some of the large Australian companies with the greatest China exposure – outside of mining conglomerates – three companies stand out. Each of these companies count sales into China as a considerable driver of revenue.

At the height of the trade tensions last year, Morningstar Australia's Director of Equity Research Adam Fleck didn't anticipate any long-term negative effects.

He conceded that any company deriving a lot of money from Chinese consumers was likely to be hurt by a slowdown in China's economy.

Conversely, Fleck said that if tariffs applied to goods from the US it would be good news for Australian companies.

China’s economy is expected to have grown 6% in October-December from a year earlier, according to analysts polled by Reuters, unchanged from the previous quarter’s pace, which was the slowest since 1992 - the earliest quarterly data on record.

Let's take a brief look at the three companies.

1. Treasury’s China sales on track

Treasury Wine Estates, a global wine company that increasingly targets high-end consumers, benefited from a drop in the tariffs China imposed on Australian winemakers in the first half of 2019 – at the same time as US wine exports to the country fell sharply.

Fleck sees continued growth in Treasury's Asian business, which comprises 26% of sales and 31% of operating income. This is largely because of the company's "premiumisation" drive in boosting its high-end brands and reducing sales of lower-end wine.

His outlook for double-digit average annual volume gains in Treasury's sales in China remains on track, forecasting 14% annual volume growth over the next several years.

"Chinese wine consumption has climbed off a low base, averaging 16% annual volume gains since 2011, as the region’s climbing consumer wealth has driven demand for upmarket brands," says Fleck.

He expects volume gains will remain "tough to come by" but believes Treasury's focus on the premium end of the market and continued growth in China and other Asian countries positions it favourably.

Treasury Wine's fair value estimate of $12.80 was lifted from $12.30 in August, on an expectation of higher margins over the long term.

But Fleck also sounds a note of caution, given the company currently trades at $17.24, some 35% above what Morningstar thinks it is worth.

2. A2 Milk's premium pricing

New Zealand-based milk and infant formula company A2 Milk has long been linked with Chinese consumers, especially in connection with professional "daigou" shoppers who legally buy the milk powder to sell overseas.

But Fleck viewed A2 as largely immune to fallout from the trade tariffs, even while highlighting sales of infant formula into China as the company's key medium-term growth avenue.

"We forecast rising prices, new products, and a continued consumer shift toward foreign brands to drive higher revenue per volume, and high-single-digit growth for overall value in the market," Fleck said in late 2019.

"We see A2 increasing revenue in this geography at a 16% annual clip through fiscal 2029, with Chinese infant formula climbing to about 90% of the company’s consolidated earnings before interest, tax, depreciation and amortisation."

He notes that A2's premium pricing gives it an advantage over other dairy producers, which has seen its operating margins top 30% from less than 1% in fiscal 2015.

"We see a ceiling to A2's profitability upside but the company's business strategy supports sky-high returns on invested capital," Fleck says.

He believes ROIC will average more than 230% over the next five years. This, combined with a debt-free balance sheet and strong free cash flow, underpins the narrow moat of competitive advantage attributed to A2 Milk.

The company's fair value estimate of $14.50 as of August last year was lifted from $13.60, on the back of solid financial results for fiscal 2019. A2 shares closed at $14.23 on Thursday and are considered fairly valued.

3. Blackmores hits some regulations

Vitamin maker Blackmores, which relies on Asia for around 40% of total group revenue, is also trading in line with Morningstar's fair value estimate.

Equity analyst Nicolette Quinn highlights China as a large opportunity for narrow-moat Blackmores, anticipating around 10% annual growth in the market from fiscal 2021.

She notes China is the second-largest global market for vitamins and dietary supplements, behind the US.

"However, the company has struggled to get across the regulatory environment, and changes in distribution channels has caused volatility," Quinn says.

Alongside the daigou channel, two key distribution methods for Blackmores are cross-border online sales and shopfront sales from supermarkets and pharmacies.

The lack of formal Chinese regulatory approval to sell from these physical storefronts continues to elude Blackmores, despite having been in the application process for more than five years.

"We understand this is a key point of focus for the new management team," Quinn says. She lifted the company's fair value estimate to $81 a share in October, following the appointment of CEO Alastair Symington and management's outline of a sustainable growth framework at its annual general meeting.

"We attribute recent disappointing performance to execution and regulatory issues, and not a changed regard for the Blackmores brand by the customer.

"Blackmores commands a price premium and its reputation for quality is its source of competitive advantage."

 

Glenn Freeman is Senior Editor at Morningstar Australia. This article is general information and does not consider the circumstances of any investor.


Try Morningstar Premium for free


 

RELATED ARTICLES

Reporting season – expect early signs of downgrading

February reporting season is the calm before the storm

Six stocks on our radar following strong reporting season

banner

Most viewed in recent weeks

Raising the GST to 15%

Treasurer Jim Chalmers aims to tackle tax reform but faces challenges. Previous reviews struggled due to political sensitivities, highlighting the need for comprehensive and politically feasible change.

7 examples of how the new super tax will be calculated

You've no doubt heard about Division 296. These case studies show what people at various levels above the $3 million threshold might need to pay the ATO, with examples ranging from under $500 to more than $35,000.

Are franking credits hurting Australia’s economy?

Business investment and per capita GDP have languished over the past decade and the Labor Government is conducting inquiries to find out why. Franking credits should be part of the debate about our stalling economy.

Here's what should replace the $3 million super tax

With Div. 296 looming, is there a smarter way to tax superannuation? This proposes a fairer, income-linked alternative that respects compounding, ensures predictability, and avoids taxing unrealised capital gains. 

The rubbery numbers behind super tax concessions

In selling the super tax, Labor has repeated Treasury claims of there being $50 billion in super tax concessions annually, mostly flowing to high-income earners. This figure is vastly overstated.

9 winning investment strategies

There are many ways to invest in stocks, but some strategies are more effective than others. Here are nine tried and tested investment approaches - choosing one of these can improve your chances of reaching your financial goals.

Latest Updates

Investment strategies

Trump's US dollar assault is fuelling CBA's rise

Australian-based investors have been perplexed by the steep rise in CBA's share price But it's becoming clear that US funds are buying into our largest bank as a hedge against potential QE and further falls in the US dollar.

Investment strategies

With markets near record highs, here's what you should do with your portfolio

Markets have weathered geopolitical turmoil, hitting near record highs. Investors face tough decisions on valuations, asset concentration, and strategic portfolio rebalancing for risk control and future returns.

Property

Soaring house prices may be locking people into marriages

Soaring house prices are deepening Australia's cost of living crisis - and possibly distorting marriage decisions. New research links unexpected price changes to whether couples separate or silently struggle together.

Investment strategies

Google is facing 'the innovator's dilemma'

Artificial intelligence is forcing Google to rethink search - and its future. As usage shifts and rivals close in, will it adapt in time, or become a cautionary tale of disrupted disruptors?

Investment strategies

Study supports what many suspected about passive investing

The surge in passive investing doesn’t just mirror the market—it shapes it, often amplifying the rise of the largest firms and creating new risks and opportunities. For investors, understanding these effects is essential.

Property

Should we dump stamp duties for land taxes?

Economists have long flagged the idea of swapping property taxes for land taxes for fairness and equity reasons. This looks at why what seems fairer may not deliver the outcomes that we expect.

Investing

Being human means being a bad investor

Many of the behaviours that have made humans such a successful species also make it difficult for us to be good, long-term investors. The key to better decision making is to understand what makes us human and adapt.

Sponsors

Alliances

© 2025 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.